Pyrazole-O-glucosides as novel Na+-glucose cotransporter (SGLT) inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pyrazole-O-glucosides as novel Na+-glucose cotransporter (SGLT) inhibitors

Published:2003-07 Issue:14 Volume:13 Page:2269-2272
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Ohsumi Koji,Matsueda Hiroyuki,Hatanaka Toshihiro,Hirama Ryusuke,Umemura Takashi,Oonuki Akiko,Ishida Nozomu,Kageyama Yoko,Maezono Katsumi,Kondo Nobuo

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference11 articles.

1. The high affinity Na+/glucose cotransporter. Re-evaluation of function and distribution of expression.

2. Molecular Characteristics of Na+-coupled Glucose Transporters in Adult and Embryonic Rat Kidney

3. SAAT1 is a low affinity Na+/glucose cotransporter and not an amino acid transporter. A reinterpretation.

4. Na+-Glucose Cotransporter Inhibitors as Antidiabetics. I. Synthesis and Pharmacological Properties of 4'-Dehydroxyphlorizin Derivatives Based on a New Concept.

5. Na+-Glucose Cotransporter (SGLT) Inhibitors as Antidiabetic Agents. 4. Synthesis and Pharmacological Properties of 4‘-Dehydroxyphlorizin Derivatives Substituted on the B Ring

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural Perspectives and Advancement of SGLT2 Inhibitors for the Treatment of Type 2 Diabetes;Current Diabetes Reviews;2021-09-17

2. Discovery of remogliflozin etabonate: A potent and highly selective SGLT2 inhibitor;Bioorganic & Medicinal Chemistry;2021-03

3. A One-Pot Divergent Sequence to Pyrazole and Quinoline Derivatives;Molecules;2020-05-05

4. Autophagy-regulating N-heterocycles derivatives as potential anticancer agents;Future Medicinal Chemistry;2020-02

5. Sodium-Glucose Transporters as a Therapeutic Target for Diabetes from the Viewpoint of Drug Discovery and Pharmacotherapy;YAKUGAKU ZASSHI;2018-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3